BioMed, Cresset Sued For $22M Over Assembly Row Development Obligation

Courtesy of BioMed Realty Trust
A Rendering Of Biomed Realty's Assembly Row Project In Somerville

A New York-based firm claims in a new lawsuit that developers BioMed Realty and Cresset Development owe it $22M from a sale for a burgeoning commercial site in Somerville.

Somerville Office Associates, the former owner of 5-7 Middlesex Ave. near Somerville’s Assembly Row, is suing the developers for breach of contract in a complaint filed last week in Suffolk County Superior Court. The firm claims the developers are rejecting payout obligations from an earlier $65M purchase of the property.

The lawsuit was first reported by the Boston Business Journal. Attorneys with Bernkopf Goodman LLP representing Somerville Office Associates and representatives for BioMed and Cresset didn't immediately respond to requests for comment Thursday.

The property includes a 162K SF building at 5 Middlesex Ave. and multiple undeveloped parcels. SOA sold the parcels in two separate deals to Cresset in 2018 and 2019, and BioMed closed on a purchase of the site from Cresset in January for $163M. BioMed is planning a 1.2M SF office, lab, research and development, and retail project.

Cresset, in its purchase of the site, included a provision granting SOA $30 for every SF exceeding 500K SF in any future permitted development, the lawsuit claims. Earlier plans by Cresset included 806K SF of new commercial development, equating to a $9M payout, per the agreement.

New development plans submitted to the city by BioMed include 1.2M SF of new commercial development, amounting to an estimated $22M payout, according to the lawsuit.

BioMed and Cresset rejected SOA’s demand for the $22M payout in a May letter, SOA claims. The developers have yet to respond to the lawsuit, which was filed June 25.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Former Randolph Event Venue Planned For 200-Room Hotel, Theater

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

140-Acre Attleboro Golf Course Hits Market, Pitched For Redevelopment

Why Research Triangle Park Life Sciences Is Turning Toward Manufacturing And Flexible Spaces

Alexandria Sells Stakes In Megacampuses To Weather Life Sciences Downturn

Nonprofit Developer Buys Mattapan Site For Affordable Housing: The Boston Deal Sheet

Downtown Office Tower Sells At Foreclosure Auction For $260M

AI Safety Nonprofit Takes 82K SF At BlackRock's King's Cross Campus

JLL Sues Ex-Life Sciences Leader, Alleging Breach Of Noncompete

FoxRock Buys Quincy Office At 78% Discount After Luring Tenant Away

Development Constraints In Massachusetts Push More Investors To Southern New Hampshire

Liberty Mutual Plans New Office Project To Consolidate HQ: The Boston Deal Sheet